Peng Liu
Jiangxi University of Traditional Chinese Medicine(CN)Emory University(US)Capital Medical University(CN)Anhui Medical University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking Union Medical College Hospital(CN)Beijing Tian Tan Hospital(CN)National Cancer Center(US)National Clinical Research Center for Digestive Diseases(CN)Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital(CN)Beijing Institute of Neurosurgery(CN)Xiyuan Hospital(CN)Beijing Hospital of Traditional Chinese Medicine(CN)Second Affiliated Hospital of Anhui Medical University(CN)Affiliated Hospital of Jining Medical University(CN)Shandong Agricultural University(CN)Jinzhou Medical University(CN)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Gout, Hyperuricemia, Uric Acid, Viral-associated cancers and disorders, Liver Disease Diagnosis and Treatment, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial(2019)234 cited
- → Liver and spleen volume variations in patients with hepatic fibrosis(2009)68 cited
- → Safety and clinical efficacy of toripalimab, a PD-1 mAb, in patients with advanced or recurrent malignancies in a phase I study(2020)65 cited
- → Role of pyroptosis in atherosclerosis and its therapeutic implications(2021)58 cited
- → Phase II Study of Hepatic Arterial Infusion Chemotherapy with Oxaliplatin and 5-Fluorouracil for Advanced Perihilar Cholangiocarcinoma(2016)57 cited
- → National Rare Diseases Registry System (NRDRS): China’s first nation-wide rare diseases demographic analyses(2021)49 cited